Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo

Trichuris trichiura is a human parasitic whipworm infecting around 500 million people globally, damaging the physical growth and educational performance of those infected. Current drug treatment options are limited and lack efficacy against the worm, preventing an eradication programme. It is theref...

Popoln opis

Bibliografske podrobnosti
Main Authors: Partridge, F, Murphy, E, Willis, N, Bataille, C, Forman, R, Heyer-Chauhan, N, Marinič, B, Sowood, D, Wynne, G, Else, K, Russell, A, Sattelle, D
Format: Journal article
Jezik:English
Izdano: Public Library of Science 2017
_version_ 1826257111329275904
author Partridge, F
Murphy, E
Willis, N
Bataille, C
Forman, R
Heyer-Chauhan, N
Marinič, B
Sowood, D
Wynne, G
Else, K
Russell, A
Sattelle, D
author_facet Partridge, F
Murphy, E
Willis, N
Bataille, C
Forman, R
Heyer-Chauhan, N
Marinič, B
Sowood, D
Wynne, G
Else, K
Russell, A
Sattelle, D
author_sort Partridge, F
collection OXFORD
description Trichuris trichiura is a human parasitic whipworm infecting around 500 million people globally, damaging the physical growth and educational performance of those infected. Current drug treatment options are limited and lack efficacy against the worm, preventing an eradication programme. It is therefore important to develop new treatments for trichuriasis. Using Trichuris muris, an established model for T. trichiura, we screened a library of 480 novel drug-like small molecules for compounds causing paralysis of the ex vivo adult parasite. We identified a class of dihydrobenz[e][1,4]oxazepin-2(3H)-one compounds with anthelmintic activity against T. muris. Further screening of structurally related compounds and resynthesis of the most potent molecules led to the identification of 20 active dihydrobenzoxazepinones, a class of molecule not previously implicated in nematode control. The most active immobilise adult T. muris with EC50 values around 25-50μM, comparable to the existing anthelmintic levamisole. The best compounds from this chemotype show low cytotoxicity against murine gut epithelial cells, demonstrating selectivity for the parasite. Developing a novel oral pharmaceutical treatment for a neglected disease and deploying it via mass drug administration is challenging. Interestingly, the dihydrobenzoxazepinone OX02983 reduces the ability of embryonated T. muris eggs to establish infection in the mouse host in vivo. Complementing the potential development of dihydrobenzoxazepinones as an oral anthelmintic, this supports an alternative strategy of developing a therapeutic that acts in the environment, perhaps via a spray, to interrupt the parasite lifecycle. Together these results show that the dihydrobenzoxazepinones are a new class of anthelmintic, active against both egg and adult stages of Trichuris parasites. They demonstrate encouraging selectivity for the parasite, and importantly show considerable scope for further optimisation to improve potency and pharmacokinetic properties with the aim of developing a clinical agent.
first_indexed 2024-03-06T18:12:57Z
format Journal article
id oxford-uuid:03a358fb-d16e-4f5e-a00d-bc7db83bc841
institution University of Oxford
language English
last_indexed 2024-03-06T18:12:57Z
publishDate 2017
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:03a358fb-d16e-4f5e-a00d-bc7db83bc8412022-03-26T08:47:25ZDihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivoJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:03a358fb-d16e-4f5e-a00d-bc7db83bc841EnglishSymplectic Elements at OxfordPublic Library of Science2017Partridge, FMurphy, EWillis, NBataille, CForman, RHeyer-Chauhan, NMarinič, BSowood, DWynne, GElse, KRussell, ASattelle, DTrichuris trichiura is a human parasitic whipworm infecting around 500 million people globally, damaging the physical growth and educational performance of those infected. Current drug treatment options are limited and lack efficacy against the worm, preventing an eradication programme. It is therefore important to develop new treatments for trichuriasis. Using Trichuris muris, an established model for T. trichiura, we screened a library of 480 novel drug-like small molecules for compounds causing paralysis of the ex vivo adult parasite. We identified a class of dihydrobenz[e][1,4]oxazepin-2(3H)-one compounds with anthelmintic activity against T. muris. Further screening of structurally related compounds and resynthesis of the most potent molecules led to the identification of 20 active dihydrobenzoxazepinones, a class of molecule not previously implicated in nematode control. The most active immobilise adult T. muris with EC50 values around 25-50μM, comparable to the existing anthelmintic levamisole. The best compounds from this chemotype show low cytotoxicity against murine gut epithelial cells, demonstrating selectivity for the parasite. Developing a novel oral pharmaceutical treatment for a neglected disease and deploying it via mass drug administration is challenging. Interestingly, the dihydrobenzoxazepinone OX02983 reduces the ability of embryonated T. muris eggs to establish infection in the mouse host in vivo. Complementing the potential development of dihydrobenzoxazepinones as an oral anthelmintic, this supports an alternative strategy of developing a therapeutic that acts in the environment, perhaps via a spray, to interrupt the parasite lifecycle. Together these results show that the dihydrobenzoxazepinones are a new class of anthelmintic, active against both egg and adult stages of Trichuris parasites. They demonstrate encouraging selectivity for the parasite, and importantly show considerable scope for further optimisation to improve potency and pharmacokinetic properties with the aim of developing a clinical agent.
spellingShingle Partridge, F
Murphy, E
Willis, N
Bataille, C
Forman, R
Heyer-Chauhan, N
Marinič, B
Sowood, D
Wynne, G
Else, K
Russell, A
Sattelle, D
Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo
title Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo
title_full Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo
title_fullStr Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo
title_full_unstemmed Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo
title_short Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo
title_sort dihydrobenz e 1 4 oxazepin 2 3h ones a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo
work_keys_str_mv AT partridgef dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT murphye dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT willisn dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT bataillec dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT formanr dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT heyerchauhann dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT marinicb dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT sowoodd dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT wynneg dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT elsek dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT russella dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo
AT sattelled dihydrobenze14oxazepin23honesanewanthelminticchemotypeimmobilisingwhipwormandreducinginfectivityinvivo